Bayer is reinvesting 2% of its Consumer Health division’s sales to drive the sustainable use of the company’s OTC brands and “help create a world where people can live healthier lives.”
Bayer AG is investing €100m ($113m) in its Consumer Health division to “enable sustainable innovation, production and consumption” of major OTC brands like Aspirin, Bepanthen, Claritin and Elevit.
Equating to 2% of the division’s sales, Bayer said the investment will help “drive the sustainable use of the company’s products and help create
At the second attempt, New Zealand’s Medicines Classification Committee supported the Rx-to-OTC switch of allopurinol (100mg and 300mg) for people suffering from gout by specifically trained pharmacists.
Stada launches nine new Oilatum products in Saudi Arabia including “rich moisturising creams for intense hydration, gentle body washes for daily cleansing, and baby-specific products like soothing bath bubbles and head-to-toe wash.”
Bayer Consumer Health, the Global Self-Care Federation and the Business Council for International Understanding outline in a paper how industry can work with multilateral organizations, governments, financial institutions, and stakeholders to "recognize and champion self-care as a fundamental driver of global health progress."
PAGB CEO Michelle Riddalls and ISF president emeritus David Webber have been awarded OBEs for their services to consumer health and self-care.
